Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis

Cancer Research

Volumn 73, Issue 11, 2013, Pages 3460-3469

  Rolfs, Frank ^a   Huber, Marcel ^d   Gruber, Florian ^e   Böhm, Friederike ^b   Pfister, Herbert J ^g   Bochkov, Valery N ^f   Tschachler, Erwin ^e   Dummer, Reinhard ^c   Hohl, Daniel ^d   Schäfer, Matthias ^a   Werner, Sabine ^a  

^a ETH ZURICH   (Switzerland)

^b Clinical Pathology   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Universitatsklinik fur Dermatologie   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIREDOXIN 6; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER PREVENTION; CANCER STAGING; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; LIPID ANALYSIS; LIPID PEROXIDATION; MOUSE; NONHUMAN; NORMAL HUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS; SKIN BIOPSY; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR CELL; WART VIRUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADULT; ANIMALS; ANTIOXIDANTS; CARCINOGENESIS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PEROXIREDOXIN VI; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS;

EID: 84878609914     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4369     Document Type: Article

References (41)

1. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9.
2. Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008;9:628-38.
3. Munz B, Frank S, Hubner G, Olsen E, Werner S. A novel type of glutathione peroxidase: expression and regulation during wound repair. Biochem J 1997;326:579-85.
4. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38:1543-52.
5. Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal 2011;15:831-44.
6. Manevich Y, Feinstein SI, Fisher AB. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A 2004; 101:3780-5.
7. Monteiro G, Horta BB, Pimenta DC, Augusto O, Netto LE. Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C. Proc Natl Acad Sci U S A 2007;104:4886-91.
8. Peshenko IV, Shichi H. Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic Biol Med 2001;31:292-303.
9. Manevich Y, Fisher AB. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 2005;38:1422-32.
10. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813-24.
11. Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004;43:326-35.
12. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
13. Kumin A, Huber C, Rulicke T, Wolf E, Werner S. Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Am J Pathol 2006;169:1194-205.
14. Kumin A, Schafer M, Epp N, Bugnon P, Born-Berclaz C, Oxenius A, et al. Peroxiredoxin 6 is required for blood vessel integrity in wounded skin. J Cell Biol 2007;179:747-60.
15. Choi H, Chang JW, Jung YK. Peroxiredoxin 6 interferes with TRAILinduced death-inducing signaling complex formation by binding to death effector domain caspase. Cell Death Differ 2011;18:405-14.
16. Pak JH, Choi WH, Lee HM, Joo WD, Kim JH, Kim YT, et al. Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest 2011;29:21-8.
17. Chang XZ, Li DQ, Hou YF, WuJ, Lu JS, Di GH, et al. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007;9:R76.
18. Ho JN, Lee SB, Lee SS, Yoon SH, Kang GY, Hwang SG, et al. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol Cancer Ther 2010;9:825-32.
19. Fujita Y, Nakanishi T, Hiramatsu M, Mabuchi H, Miyamoto Y, Miyamoto A, et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 2006;12:6415-20.
20. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 2007;7:375-80.
21. Wang X, Phelan SA, Forsman-Semb K, Taylor EF, Petros C, Brown A, et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 2003;278: 25179-90.
22. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005;65:1394-400.
23. Gruber F, Bicker W, Oskolkova OV, Tschachler E, Bochkov VN. A simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation. J Lipid Res 2012; 53:1232-42.
24. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-89.
25. Abel EL, Angel JM, Kiguchi K, DiGiovanni J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 2009;4:1350-62.
26. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 1993;14: 2353-8.
27. Antsiferova M, Huber M, Meyer M, Piwko-Czuchra A, Ramadan T, MacLeod AS, et al. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nat Commun 2011;2:576.
28. Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K, Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 2002;33:192-200.
29. Fisher AB, Dodia C, Manevich Y, Chen JW, Feinstein SI. Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J Biol Chem 1999;274:21326-34.
30. Manevich Y, Shuvaeva T, Dodia C, Kazi A, Feinstein SI, Fisher AB. Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A(2) activities. Arch Biochem Biophys 2009;485:139-49.
31. Beckman JK, Bagheri F, Ji C, Blair IA, Marnett LJ. Phospholipid peroxidation in tumor promoter-exposed mouse skin. Carcinogenesis 1994;15:2937-44.
32. Marcuzzi GP, Hufbauer M, Kasper HU, Weissenborn SJ, Smola S, Pfister H. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009;90:2855-64.
33. Hufbauer M, Lazic D, Reinartz M, Akgul B, Pfister H, Weissenborn SJ. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. J Dermatol Sci 2011;64:7-15.
34. auf dem Keller U, Huber M, Beyer TA, Kumin A, Siemes C, Braun S, et al. Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol Cell Biol 2006;26: 3773-84.
35. Frenkel K, Wei L, Wei H. 7, 12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic Biol Med 1995;19: 373-80.
36. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006;126:2565-75.
37. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, et al. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 1997;57: 1468-74.
38. Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, Yen HC, et al. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 2001;61: 6082-8.
39. St Clair D, Zhao Y, Chaiswing L, Oberley T. Modulation of skin tumorigenesis by SOD. Biomed Pharmacother 2005;59:209-14.
40. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
41. Was H, Sokolowska M, Sierpniowska A, Dominik P, Skrzypek K, Lackowska B, et al. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic Biol Med 2011;51:1717-26.